FDA PMA FDA Class 3 Approved 🇺🇸 United States

Implantable Pacemaker Pulse-Generator

PMA: P990001 · Supplement: S014 · Decision Sep 16, 2003
Classifications
1
FEI Numbers
28
Registration Numbers
28

Basic Information

Device Name
Implantable Pacemaker Pulse-Generator
Trade Name
VITATRON DA+ C SERIES PULSE GENERATORS
PMA Number
P990001
Supplement Number
S014
Device Class
FDA Class 3
Product Code
DXY
Generic Name
implantable pacemaker Pulse-generator
Regulation Number
870.3610
Medical Specialty
Cardiovascular
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
September 16, 2003
Date Received
February 20, 2003
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR MODIFICATIONS TO RATE RESPONSE FEATURES, ADDITION OF TELEMETRY B, AND OTHER DIAGNOSTIC ENHANCEMENTS. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME MEDTRONIC/VITATRON DA+ C-SERIES IMPLANTABLE GENERATORS AND IS INDICATED AS FOLLOWS: 1) DUAL CHAMBER PACING IS INDICATED IF AV SYNCHRONY NEEDS TO BE RESTORED IN ORDER TO OPTIMIZE CARDIAC OUTPUT. FOR EXAMPLE, PATIENTS WITH SYMPTOMATIC SECOND OR THIRD DEGREE AV BLOCK. 2) DUAL CHAMBER RATE RESPONSIVE PACING MODES ARE OF SPECIFIC BENEFIT TO PATIENTS WITH CHRONOTROPIC INCOMPETENCE OF THE SINUS NODE. 3) RATE RESPONSIVE MODES CAN HELP PATIENTS WHO HAVE A REQUIREMENT FOR ANINCREASE IN PACING RATE IN RESPONSE TO PHYSICAL ACTIVITY. 4) SINGLE CHAMBER VENTRICULAR PACING CAN HELP PATIENTS WITH PERMANENT ATRIALTACHYARRHYTHMIAS, INCLUDING ATRIAL FIBRILLATION AND FLUTTER. 5) SINGLE CHAMBER ATRIAL PACING CAN HELP PATIENTS WITH SYMPTOMATIC BRADYARRHYTHMIASAND NORMAL AV CONDUCTION.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
DXY Implantable Pacemaker Pulse-Generator